Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Akumin Appoints President and Chief Operating Officer
Akumin, a national partner of choice for U.S. hospitals, health systems and physician groups, with […]
Morphimmune Appoints Dr. Clay Siegall Chief Executive Officer and President
Morphimmune, a preclinical biotechnology company focused on developing targeted oncology therapeutics, today announced the appointment […]
Phio Pharmaceuticals Appoints Robert Bitterman as President and Chief Executive Officer
Phio Pharmaceuticals, a clinical-stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to […]
enGene Appoints Alex Nichols, PhD as President and Chief Operating Officer
enGene, a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more